, /PRNewswire/ -- , a commercial-stage medical diagnostics company focused on advancing early detection technologies to diagnose fast-moving and immune-mediated diseases, today announced that the first hospital to commercially implement the company's rapid sepsis diagnostic has now screened over 5,000 patients with the test. , part of the in , added the IntelliSep test to the hospital's sepsis management program in and the technology has become a critical first-line triage tool to quickly detect or rule-out sepsis in the emergency department (ED). Sepsis is the , in large part because clinicians have not had a rapid diagnostic to objectively detect sepsis.
The IntelliSep test generates results in about eight minutes using a standard blood draw, and can be seamlessly and efficiently integrated into existing ED care workflows. According to a , the test enabled the Our Lady of the Lake Regional Medical Center team to shorten the length of stay of IntelliSep-tested patients by an average of 1.28 days and significantly decrease the amount of blood cultures drawn and antibiotics delivered.
This may translate into lower risks for patients, decreased time away from family and work, and fewer unnecessary interventions and antibiotic exposure. The study also documented savings of about per patient tested. "As a mission-driven healthcare provider, Franciscan Missionaries of Our Lady Health System is committed to the highest level of sepsis care for the communities we are privileged to s.
